Skip to main content

Table 1 Summary of visits and content

From: Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)

Instrument

Assessment

Timing of assessment

Inclusion form

Eligibility criteria

Previous to randomization

Sociodemographic form of patient and caregiver

Sociodemographic data

Basal

Baseline clinical data form

Treatment for dementia

Diseases and concomitant treatments

Basal

Institucionalization form

Institutionalization date

1,3,6 & 12 months (study end)

SMMSE

Cognitive assessment

Basal, 1,3,6 & 12 months (study end)

BADLS

Functional assessment

Basal, 1,3,6 & 12 months (study end)

FAST

Functional assessment

Basal & 12 months (study end)

QUALID

Advanced dementia quality of life

Basal, 1,3,6 & 12 months (study end)

EQ-5D

Quality of life related to health

Basal & 12 months (study end)

NPI-Q

Psychological and behavioral symptoms associated to dementia

Basal, 1,3,6 & 12 months (study end)

Zarit Scale

Caregiver overload

Basal, 1,3,6 & 12 months (study end)

CGIC

Clinical improvement impression

12 months (study end)

RUD Lite

Use of health resources in dementia

12 months (study end)

Adverse effects forms

Safety, adverse effects and mortality

1,3,6 & 12 months (study end)